Related Experiment Video

Updated: Jun 20, 2026

Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models
10:04

Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models

Published on: March 13, 2018

Nuclear imaging of molecular processes in cancer

Rafael Torres Martin de Rosales1, Erik Arstad, Philip J Blower

  • 1King's College London, Division of Imaging Sciences, Rayne Institute, St Thomas' Hospital, 4th Floor Lambeth Wing, London, SE1 7EH, UK.

Targeted Oncology
|September 26, 2009
PubMed

Insights

Molecular imaging with radionuclides allows visualization of biological processes using radiotracers. This overview covers positron emission tomography and single photon radionuclide imaging for cancer research and clinical applications.

Area of Science:

  • * Nuclear medicine and molecular imaging.
  • * Biomedical research and diagnostics.

Background:

  • * Molecular imaging enables visualization of molecular processes in vivo.
  • * Radiotracers, at low concentrations, image specific targets without perturbing biological functions.
  • * Applications include imaging peptide receptors, angiogenesis, drug resistance, hypoxia, and metabolism.

Purpose of the Study:

  • * To provide a non-specialist overview of radionuclide imaging technologies.
  • * To discuss positron emission tomography (PET) and single photon radionuclide imaging (SPRI).
  • * To highlight radiolabeled molecules for cancer research and clinical use.

Main Methods:

  • * Review of positron emission tomography (PET) principles.
  • * Review of single photon radionuclide imaging (SPRI) principles.
  • * Discussion of radiolabeled molecules and their applications in cancer.

Main Results:

  • * PET and SPRI are key radionuclide imaging modalities.
  • * Various molecular targets in cancer can be imaged using radiotracers.
  • * Development of novel radiotracers is ongoing for research and clinical applications.

Conclusions:

  • * Radionuclide imaging offers powerful tools for molecular process visualization.
  • * PET and SPRI are crucial for advancing cancer research and patient care.
  • * Continued development of radiotracers will expand molecular imaging applications in oncology.

More Related Videos

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines07:59

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

Published on: March 4, 2017

Related Concept Videos

Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Positron Emission Tomography01:29

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
Applications Of NMR In Biology01:25

Applications Of NMR In Biology

Nuclear magnetic resonance (NMR) spectroscopy is a very valuable analytical technique for researchers. It has been used for more than 50 years as an analytical tool. F. Bloch and E. Purcell formulated NMR in 1946 and won the 1952 Nobel Prize in Physics  for their work. Biological macromolecules such as proteins, nucleic acids, lipids, and organic molecules including pharmaceutical compounds, can be studied using this versatile tool that exploits the magnetic properties of certain nuclei.
The...
Nuclear Magnetic Resonance (NMR): Overview01:07

Nuclear Magnetic Resonance (NMR): Overview

Nuclear magnetic resonance (NMR) is a phenomenon exhibited by certain nuclei that can absorb characteristic radio frequency radiation under certain conditions. NMR has been extensively applied in molecular spectroscopy and medical diagnostic imaging. In both these applications, the molecule or subject under study is placed in a magnetic field and irradiated with radio frequency energy.
NMR spectroscopy generates a spectrum where the characteristic absorption frequencies of the sample are...
Radiological Investigation III: Pulmonary Angiogram and PET Scan01:13

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
Magnetic Resonance Imaging01:24

Magnetic Resonance Imaging

Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...